INDIANAPOLIS — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs.
The Basel-based company, whose array of products includes cancer medicines and multiple sclerosis treatment Ocrevus, said the investment would go toward high-tech research and development sites and new manufacturing facilities in places including California, Indiana, Massachusetts and Pennsylvania.
Some of the $50 billion in investments were already underway or planned for the next several years, Roche spokesperson Rebekka Schnell said in an e-mail, adding that the company was not specifying how much was announced for the first time on Tuesday…